research use only

Emodepside Parasite inhibitor

Cat.No.S0467

Emodepside (QHT06, BAY 44-4400, PF 1022-221), a semisynthetic derivative of PF1022A, is a cyclooctadepsipeptide with broad-spectrum anthelmintic activity. This compound activates Ca-dependent SLO-1-like K channels.
Jump to

Quality Control

Batch: S046701 DMSO]100 mg/mL]false]Ethanol]20 mg/mL]false]Water]Insoluble]false Purity: 99.67%
99.67

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (89.33 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 20 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 1119.39 Formula

C60H90N6O14

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 155030-63-0 -- Storage of Stock Solutions

Synonyms QHT06, BAY 44-4400, PF 1022-221 SMILES CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
Ca-dependent SLO-1-like K channels
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-14)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06800248 NOT_YET_RECRUITING
Trichuris Trichiura; Infection; Hookworm Infection; Ascaris Lumbricoides Infection
Swiss Tropical & Public Health Institute
2026-11-06 PHASE3
NCT07258173 NOT_YET_RECRUITING
Trichuris Infection
Jennifer Keiser
2026-11-15 PHASE2
NCT05180461 ACTIVE_NOT_RECRUITING
Onchocerciasis
Drugs for Neglected Diseases
2021-08-30 PHASE2
NCT06736691 ACTIVE_NOT_RECRUITING
Trichuris Trichiura; Infection; Hookworm Infection; Ascaris Lumbricoides Infection
Swiss Tropical & Public Health Institute
2025-11-25 PHASE3
NCT06373835 COMPLETED
Strongyloides Stercoralis Infection; Strongyloidiasis
Swiss Tropical & Public Health Institute
2024-05-20 PHASE2
NCT06412926 COMPLETED
Soil-transmitted Helminth Infection; Onchocerciasis (River Blindness)
Bayer
2024-05-07 PHASE1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.